Tech Center 1700 • Art Units: 1625 1641 1645 1674 1677 1678 1758
This examiner grants 34% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18044371 | SYSTEMS AND METHODS FOR THE AMPLIFIED DETECTION OF MOLECULES ON MICROPARTICLES | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18300689 | ELECTROCHEMILUMINESCENCE METHOD OF DETECTING AN ANALYTE IN A LIQUID SAMPLE AND ANALYSIS SYSTEM | Final Rejection | Hitachi High-Tech Corporation |
| 18133908 | HIGH-THROUGHPUT FLOW CYTOMETRY ANALYSIS OF HIGHLY MULTIPLEXED SAMPLES USING SAMPLE INDEXING WITH SPECIFIC BINDING MEMBER-FLUOR CONJUGATES | Non-Final OA | Becton, Dickinson and Company |
| 18126819 | SINGLE DOMAIN ANTIBODY/POLYMERIC TANDEM FLUORESCENT DYE CONJUGATES, AND METHODS FOR MAKING AND USING THE SAME | Non-Final OA | Becton, Dickinson and Company |
| 18004402 | SINGLE-MOLECULE, REAL-TIME, LABEL-FREE DYNAMIC BIOSENSING WITH NANOSCALE MAGNETIC FIELD SENSORS | Final Rejection | Western Digital Technologies, Inc. |
| 17923148 | METHOD OF USING EXTRACELLULAR VESICLES TO DETECT COMPLEMENT ACTIVATION, AND USES THEREOF TO ASSESS AND/OR MONITOR TREATMENT OF A COMPLEMENT-MEDIATED DISEASE | Non-Final OA | Alexion Pharmaceuticals, Inc. |
| 17952897 | METHOD FOR MEASURING THE PROTEASE ACTIVITY OF C3 AND C5 CONVERTASE OF THE ALTERNATIVE COMPLEMENT PATHWAY | Final Rejection | Alexion Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy